What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to formally announce and provide access to CVS Health's financial results for the fourth quarter and full year ended December 31, 2019, through an accompanying press release.

Where can I find the detailed financial results?

The detailed financial results are primarily located in the press release, furnished as Exhibit 99.1 to this 8-K filing. You will need to refer to that document for specific numbers on revenue, earnings, and other financial metrics.

Does this 8-K filing contain the full financial statements?

No, this particular 8-K filing does not contain the full financial statements directly. It incorporates the press release by reference, which summarizes the key financial results. More detailed financial statements would typically be found in the company's subsequent Form 10-Q (quarterly) or 10-K (annual) filings.

What is the significance of the 'not deemed filed' disclaimer?

The disclaimer means that the information provided in this specific 8-K and its exhibits is not automatically considered part of a 'registration statement' or subject to the liabilities under Section 18 of the Exchange Act, unless the company explicitly incorporates it into other SEC filings. It's a standard practice for earnings release disclosures furnished under Item 2.02.

CVS 8-K: Earnings & Results

Summary

CVS Health Corporation (CVS) filed an 8-K on February 12, 2020, to announce its financial results for the fourth quarter and full year ended December 31, 2019. The filing primarily consists of a press release (Exhibit 99.1) detailing these results. Investors should refer to this press release for specific financial performance metrics, including revenue, earnings per share, and other operational highlights for the period. The 8-K itself does not contain detailed financial statements but incorporates the press release by reference. While the 8-K filing is routine for announcing quarterly and annual results, it's crucial for investors to access and review the furnished press release. This document will provide the quantitative data necessary to assess CVS Health's performance against expectations, evaluate its financial health, and understand the company's trajectory heading into the subsequent fiscal year. Key takeaways will likely involve the impact of the Aetna acquisition and performance across CVS's various segments, including Pharmacy Services, Retail/LTC, and Health Care Benefits.

Key Highlights

1CVS Health announced its fourth quarter and full year 2019 financial results via a press release furnished with the 8-K filing.
2The filing was made on February 12, 2020, reporting on the period ending December 31, 2019.
3The primary content is Exhibit 99.1, the press release detailing the company's operational and financial performance.
4Investors are directed to the press release for specific financial figures and operational updates.
5The 8-K filing itself does not contain detailed financial statements but incorporates the press release by reference.
6The information furnished is not deemed 'filed' for certain SEC purposes, meaning it doesn't automatically trigger liabilities under specific sections of the Exchange Act unless incorporated by reference in other filings.

CVS HEALTH Corp 8-K Report, Financial Results (Feb 12, 2020)

Summary

Key Highlights

Frequently Asked Questions